Malaria remains one of the most significant health problems in the
world today. Pregnant women, their babies and young children are
particularly at risk. Applying our comprehensive perspective, FHI 360
researchers study, among other important topics: Malaria in pregnancy
Malaria co-infection with HIV and tuberculosis Socioeconomic and
behavioral aspects of malaria prevention Best treatments for severe
malaria in children FHI 360 partnered with leading researchers to
monitor a research study in Africa comparing the effectiveness of two
drugs for treating the most severe form of malaria in children younger
than age 15. The results suggest that, if used to treat the 4 million
annual cases of malaria in this population, the drug artesunate could
save about 100,000 lives each year. Leveraging public–private
partnerships, our programs have tested and distributed millions of
insecticide-treated bed nets. We have also designed innovative
communication programs to encourage consistent use of the nets and
increased the capacity of local producers and distributors to ensure
adequate net supplies in the future. FHI 360 works to improve access
to quality malaria prevention and treatment services and supports the
development of more effective antimalarial drugs. To build a more
productive workforce, we work with large local employers in
high-incidence areas to improve prevention and early treatment. Taking
a comprehensive approach, we integrate malaria prevention and
treatment into our HIV/AIDS, family planning, tuberculosis and other
infectious disease programs in Africa and Asia, the regions most
affected by malaria.
